Additionally, high TIGIT levels are linked to greater severity in lung adenocarcinoma, and patients with overexpressed CD155 in lung adenocarcinoma and SCLC have shorter progression-free survival and overall survival (46–48). This evidence concerns the gene TIGIT and lung adenocarcinoma.